Revenue: The sum of all revenue fields included for a company's operating activities.
Poniard Pharmaceuticals Inc. (PARD) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-3.77M |
|
-- |
|
-- |
|
$3.74M |
|
$-3.74M |
|
$-0.02M |
|
$-3.77M |
|
$-3.77M |
|
$-3.77M |
|
$-3.77M |
|
$-3.77M |
|
$-3.77M |
|
$-3.74M |
|
$-3.43M |
|
1.50M |
|
1.50M |
|
$-2.40 |
|
$-2.40 |
|
| Balance Sheet Financials | |
$2.25M |
|
$0.71M |
|
$6.17M |
|
$7.73M |
|
$2.97M |
|
$1.64M |
|
$1.64M |
|
$4.61M |
|
$3.10M |
|
$-2.34M |
|
$3.11M |
|
-- |
|
| Cash Flow Statement Financials | |
$-5.41M |
|
$3.02M |
|
$3.08M |
|
$1.28M |
|
$1.98M |
|
$0.70M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.76 |
|
-- |
|
-- |
|
0.35 |
|
0.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-121.64% |
|
161.15% |
|
-48.78% |
|
-79.39% |
|
-- |
|
$-3.62 |
|
$-3.61 |
|